{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T16:40:28Z","timestamp":1784133628983,"version":"3.55.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2007,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Glycated haemoglobin (HbA<jats:sub>1c<\/jats:sub>), blood pressure and body mass index (BMI) are risk factors for albuminuria, the latter in turn can lead to hyperlipidaemia. We used novel statistical analyses to examine how albuminuria and chronic kidney disease (CKD) may influence the effects of other risk factors on coronary heart disease (CHD).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A prospective cohort of 7067 Chinese type 2 diabetic patients without history of CHD enrolled since 1995 were censored on July 30<jats:sup>th<\/jats:sup>, 2005. Cox proportional hazard regression with restricted cubic spline was used to auto-select predictors. Hazard ratio plots were used to examine the risk of CHD. Based on these plots, non-linear risk factors were categorised and the categorised variables were refitted into various Cox models in a stepwise manner to confirm the findings.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Age, male gender, duration of diabetes, spot urinary albumin: creatinine ratio, estimated glomerular filtration rate, total cholesterol (TC), high density lipoprotein cholesterol (HDL-C) and current smoking status were risk factors of CHD. Linear association between TC and CHD was observed only in patients with albuminuria. Although in general, increased HDL-C was associated with decreased risk of CHD, full-range HDL-C was associated with CHD in an A-shaped manner with a zenith at 1.1 mmol\/L. Albuminuria and CKD were the main contributors for the paradoxically positive association between HDL-C and CHD for HDL-C values less than 1.1 mmol\/L.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>In type 2 diabetes, albuminuria plays a linking role between conventional risk factors and CHD. The onset of CKD changes risk associations between lipids and CHD.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1475-2840-6-37","type":"journal-article","created":{"date-parts":[[2007,12,4]],"date-time":"2007-12-04T07:13:34Z","timestamp":1196752414000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Impacts of chronic kidney disease and albuminuria on associations between coronary heart disease and its traditional risk factors in type 2 diabetic patients \u2013 the Hong Kong diabetes registry"],"prefix":"10.1186","volume":"6","author":[{"given":"Xilin","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald C","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wing-Yee","family":"So","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary T","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice P","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher W","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Shun","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clive S","family":"Cockram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian C","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana C","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,12,2]]},"reference":[{"key":"116_CR1","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/S0140-6736(96)07493-4","volume":"349","author":"CJ Murray","year":"1997","unstructured":"Murray CJ, Lopez AD: Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet. 1997, 349: 1269-1276. 10.1016\/S0140-6736(96)07493-4.","journal-title":"Lancet"},{"key":"116_CR2","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1046\/j.1365-2796.2001.00789.x","volume":"249","author":"M Laakso","year":"2001","unstructured":"Laakso M: Cardiovascular disease in type 2 diabetes: challenge for treatment and prevention. J Intern Med. 2001, 249: 225-235. 10.1046\/j.1365-2796.2001.00789.x.","journal-title":"J Intern Med"},{"issue":"1734","key":"116_CR3","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1136\/bmj.316.7134.823","volume":"316","author":"RC Turner","year":"1998","unstructured":"Turner RC, Millns H, Neil HA, Stratton IM, Manley SE, Matthews DR, Holman RR: Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). BMJ. 1998, 316 (1734): 823-828.","journal-title":"BMJ"},{"key":"116_CR4","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1161\/01.CIR.0000139860.33974.28","volume":"110","author":"D de Zeeuw","year":"2004","unstructured":"de Zeeuw D, Remuzzi G, Parving HH, Keane WF, Zhang Z, Shahinfar S, Snapinn S, Cooper ME, Mitch WE, Brenner BM: Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation. 2004, 110: 921-927. 10.1161\/01.CIR.0000139860.33974.28.","journal-title":"Circulation"},{"key":"116_CR5","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1111\/j.1523-1755.2005.00526.x","volume":"68","author":"Z Wang","year":"2005","unstructured":"Wang Z, Hoy WE: Albuminuria and incident coronary heart disease in Australian Aboriginal people. Kidney Int. 2005, 68: 1289-1293. 10.1111\/j.1523-1755.2005.00526.x.","journal-title":"Kidney Int"},{"key":"116_CR6","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1093\/aje\/kwh037","volume":"159","author":"MF Yuyun","year":"2004","unstructured":"Yuyun MF, Khaw KT, Luben R, Welch A, Bingham S, Day NE, Wareham NJ: A prospective study of microalbuminuria and incident coronary heart disease and its prognostic significance in a British population: the EPIC-Norfolk study. Am J Epidemiol. 2004, 159: 284-293. 10.1093\/aje\/kwh037.","journal-title":"Am J Epidemiol"},{"key":"116_CR7","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S0735-1097(02)01910-1","volume":"40","author":"MK Rutter","year":"2002","unstructured":"Rutter MK, Wahid ST, McComb JM, Marshall SM: Significance of silent ischemia and microalbuminuria in predicting coronary events in asymptomatic patients with type 2 diabetes. J Am Coll Cardiol. 2002, 40: 56-61. 10.1016\/S0735-1097(02)01910-1.","journal-title":"J Am Coll Cardiol"},{"key":"116_CR8","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1681\/ASN.2006050517","volume":"17","author":"D de Zeeuw","year":"2006","unstructured":"de Zeeuw D, Parving HH, Henning RH: Microalbuminuria as an early marker for cardiovascular disease. J Am Soc Nephrol. 2006, 17: 2100-2105. 10.1681\/ASN.2006050517.","journal-title":"J Am Soc Nephrol"},{"key":"116_CR9","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.diabres.2004.07.021","volume":"67","author":"J Cederholm","year":"2005","unstructured":"Cederholm J, Eliasson B, Nilsson PM, Weiss L, Gudbjornsdottir S: Microalbuminuria and risk factors in type 1 and type 2 diabetic patients. Diabetes Res Clin Pract. 2005, 67: 258-266. 10.1016\/j.diabres.2004.07.021.","journal-title":"Diabetes Res Clin Pract"},{"key":"116_CR10","first-page":"658","volume":"17","author":"A Shankar","year":"2004","unstructured":"Shankar A, Klein R, Moss SE, Klein BE, Wong TY: The relationship between albuminuria and hypercholesterolemia. J Nephrol. 2004, 17: 658-665.","journal-title":"J Nephrol"},{"key":"116_CR11","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.2337\/dc06-0248","volume":"29","author":"WY So","year":"2006","unstructured":"So WY, Kong AP, Ma RC, Ozaki R, Szeto CC, Chan NN, Ng V, Ho CS, Lam CW, Chow CC, Cockram CS, Chan JC, Tong PC: Glomerular filtration rate, cardiorenal end points, and all-cause mortality in type 2 diabetic patients. Diabetes Care. 2006, 29: 2046-2052. 10.2337\/dc06-0248.","journal-title":"Diabetes Care"},{"key":"116_CR12","doi-asserted-by":"publisher","first-page":"S55","DOI":"10.1038\/sj.ki.5001979","volume":"70","author":"GA Kaysen","year":"2006","unstructured":"Kaysen GA: Dyslipidemia in chronic kidney disease: Causes and consequences. Kidney Int. 2006, 70: S55-S58. 10.1038\/sj.ki.5001979.","journal-title":"Kidney Int"},{"key":"116_CR13","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/j.1464-5491.1993.tb00083.x","volume":"10","author":"K Piwernetz","year":"1993","unstructured":"Piwernetz K, Home PD, Snorgaard O, Antsiferov M, Staehr-Johansen K, Krans M: For the DiabCare Monitoring Group of the St. Vincent Declaration Steering Committee. Monitoring the targets of the St. Vincent declaration and the implementation of quality management in diabetes care: the DiabCare initiative. Diabet Med. 1993, 10: 371-377.","journal-title":"Diabet Med"},{"key":"116_CR14","doi-asserted-by":"publisher","first-page":"114","DOI":"10.2337\/diacare.8.2.114","volume":"8","author":"M Laakso","year":"1985","unstructured":"Laakso M, Pyorala K: Age of onset and type of diabetes. Diabetes Care. 1985, 8: 114-117. 10.2337\/diacare.8.2.114.","journal-title":"Diabetes Care"},{"key":"116_CR15","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1161\/01.HYP.0000137192.19577.c3","volume":"44","author":"WY So","year":"2004","unstructured":"So WY, Ozaki R, Chan NN, Tong PC, Ho CS, Lam CW, Ko GT, Chow CC, Chan WB, Ma RC, Chan JC: Effect of angiotensin-converting enzyme inhibition on survival in 3773 Chinese type 2 diabetic patients. Hypertension. 2004, 44: 294-299. 10.1161\/01.HYP.0000137192.19577.c3.","journal-title":"Hypertension"},{"key":"116_CR16","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1007\/s00125-006-0376-3","volume":"49","author":"XL Yang","year":"2006","unstructured":"Yang XL, So WY, Kong AP, Clarke P, Ho CS, Lam CW, Ng MH, Lyu RR, Yin DD, Chow CC, Cockram CS, Tong PC, Chan JC: End-stage renal disease risk equations for Hong Kong Chinese patients with type 2 diabetes: Hong Kong Diabetes Registry. Diabetologia. 2006, 49: 2299-2308. 10.1007\/s00125-006-0376-3.","journal-title":"Diabetologia"},{"key":"116_CR17","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1681\/ASN.2006040368","volume":"17","author":"YC Ma","year":"2006","unstructured":"Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y, Xu JS, Huang SM, Wang LN, Huang W, Wang M, Xu GB, Wang HY: Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006, 17: 2937-44. 10.1681\/ASN.2006040368.","journal-title":"J Am Soc Nephrol"},{"key":"116_CR18","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4757-3462-1","volume-title":"Regression Modelling Strategies with applications to Linear Models, Logistic Regression, and Survival Analysis","author":"F Harrell","year":"2001","unstructured":"Harrell F: Regression Modelling Strategies with applications to Linear Models, Logistic Regression, and Survival Analysis. 2001, New York: Spinger-Varlag New York, Inc"},{"key":"116_CR19","volume-title":"Diabetes Metab Res Rev","author":"WY So","year":"2007","unstructured":"So WY, Yang XL, Ma RC, Kong AP, Lam CW, Ho CS, Cockram CS, Ko GT, Chow CC, Wong V, Tong PC, Chan JC: Risk factors in V-shaped risk associations with all-cause mortality in type 2 diabetes -The Hong Kong Diabetes Registry. Diabetes Metab Res Rev. 2007, Published online in Wiley InterScience. DOI:10.1002\/dmrr.792, [http:\/\/www3.interscience.wiley.com\/cgi-bin\/home?CRETRY=1&SRETRY=0]"},{"key":"116_CR20","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1093\/biomet\/80.3.557","volume":"80","author":"DY Lin","year":"1993","unstructured":"Lin DY, Wei LJ, Ying Z: Checking the Cox Model with Cumulative Sums of Martingale-Based Residuals. Biometrika. 1993, 80: 557-572. 10.1093\/biomet\/80.3.557.","journal-title":"Biometrika"},{"key":"116_CR21","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1161\/01.RES.0000146094.59640.13","volume":"95","author":"PJ Barter","year":"2004","unstructured":"Barter PJ, Nicholls S, Rye KA, Anantharamaiah GM, Navab M, Fogelman AM: Antiinflammatory properties of HDL. Circ Res. 2004, 95: 764-772. 10.1161\/01.RES.0000146094.59640.13.","journal-title":"Circ Res"},{"key":"116_CR22","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.pharmthera.2006.02.003","volume":"111","author":"MJ Chapman","year":"2006","unstructured":"Chapman MJ: Therapeutic elevation of HDL-cholesterol to prevent atherosclerosis and coronary heart disease. Pharmacol Ther. 2006, 111: 893-908. 10.1016\/j.pharmthera.2006.02.003.","journal-title":"Pharmacol Ther"},{"issue":"Suppl 7","key":"116_CR23","first-page":"vii2","volume":"18","author":"F Locatelli","year":"2003","unstructured":"Locatelli F, Pozzoni P, Tentori F, del Vecchio L: Epidemiology of cardiovascular risk in patients with chronic kidney disease. Nephrol Dial Transplant. 2003, 18 (Suppl 7): vii2-9.","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"116_CR24","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/j.1365-2249.2007.03389.x","volume":"149","author":"CK Wong","year":"2007","unstructured":"Wong CK, Ho AW, Tong PC, Yeung CY, Kong AP, Lun SW, Chan JC, Lam CW: Aberrant activation profile of cytokines and mitogen-activated protein kinases in type 2 diabetic patients with nephropathy. Clin Exp Immunol. 2007, 149 (1): 123-131. doi:10.1111\/j.1365-2249.2007.03389.x","journal-title":"Clin Exp Immunol"},{"key":"116_CR25","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1056\/NEJMoa043545","volume":"353","author":"C Wanner","year":"2005","unstructured":"Wanner C, Krane V, Marz W, Olschewski M, Mann JF, Ruf G, Ritz E, German Diabetes and Dialysis Study Investigators: Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med. 2005, 353: 238-248. 10.1056\/NEJMoa043545.","journal-title":"N Engl J Med"},{"key":"116_CR26","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1056\/NEJMoa070635","volume":"356","author":"SE Nissen","year":"2007","unstructured":"Nissen SE, Tardif JC, Nicholls SJ, Revkin JH, Shear CL, Duggan WT, Ruzyllo W, Bachinsky WB, Lasala GP, Tuzcu EM, ILLUSTRATE Investigators: Effect of torcetrapib on the progression of coronary atherosclerosis. N Engl J Med. 2007, 356: 1304-1316. 10.1056\/NEJMoa070635.","journal-title":"N Engl J Med"},{"key":"116_CR27","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1056\/NEJMoa071359","volume":"356","author":"JJ Kastelein","year":"2007","unstructured":"Kastelein JJ, van Leuven SI, Burgess L, Evans GW, Kuivenhoven JA, Barter PJ, Revkin JH, Grobbee DE, Riley WA, Shear CL, Duggan WT, Bots ML, RADIANCE 1 Investigators: Effect of Torcetrapib on Carotid Atherosclerosis in Familial Hypercholesterolemia. N Engl J Med. 2007, 356: 1620-1630. 10.1056\/NEJMoa071359.","journal-title":"N Engl J Med"},{"key":"116_CR28","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1111\/j.1523-1755.2002.kid571.x","volume":"62","author":"RM Henry","year":"2002","unstructured":"Henry RM, Kostense PJ, Bos G, Dekker JM, Nijpels G, Heine RJ, Bouter LM, Stehouwer CD: Mild renal insufficiency is associated with increased cardiovascular mortality: The Hoorn Study. Kidney Int. 2002, 62: 1402-1407. 10.1111\/j.1523-1755.2002.kid571.x.","journal-title":"Kidney Int"},{"key":"116_CR29","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1001\/jama.286.4.421","volume":"286","author":"HC Gerstein","year":"2001","unstructured":"Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, Halle JP, Young J, Rashkow A, Joyce C, Nawaz S, Yusuf S, HOPE Study Investigators: Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA. 2001, 286: 421-426. 10.1001\/jama.286.4.421.","journal-title":"JAMA"},{"key":"116_CR30","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1097\/01.ASN.0000092138.65211.71","volume":"14","author":"CT Jurkovitz","year":"2003","unstructured":"Jurkovitz CT, Abramson JL, Vaccarino LV, Weintraub WS, McClellan WM: Association of high serum creatinine and anemia increases the risk of coronary events: results from the prospective community-based atherosclerosis risk in communities (ARIC) study. J Am Soc Nephrol. 2003, 14: 2919-2925. 10.1097\/01.ASN.0000092138.65211.71.","journal-title":"J Am Soc Nephrol"},{"key":"116_CR31","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1159\/000074920","volume":"22","author":"A Levin","year":"2004","unstructured":"Levin A: Cardiac disease in chronic kidney disease: current understandings and opportunities for change. Blood Purif. 2004, 22: 21-27. 10.1159\/000074920.","journal-title":"Blood Purif"},{"key":"116_CR32","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1056\/NEJMoa062276","volume":"355","author":"TB Drueke","year":"2006","unstructured":"Drueke TB, Locatelli F, Clyne N, Eckardt KU, Macdougall IC, Tsakiris D, Burger HU, Scherhag A, CREATE Investigators: Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med. 2006, 355: 2071-2084. 10.1056\/NEJMoa062276.","journal-title":"N Engl J Med"},{"key":"116_CR33","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1056\/NEJMoa065485","volume":"355","author":"AK Singh","year":"2006","unstructured":"Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, Wolfson M, Reddan D, CHOIR Investigators: Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med. 2006, 355: 2085-2098. 10.1056\/NEJMoa065485.","journal-title":"N Engl J Med"},{"key":"116_CR34","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.2337\/diab.46.8.1354","volume":"46","author":"S Lehto","year":"1997","unstructured":"Lehto S, Ronnemaa T, Haffner SM, Pyorala K, Kallio V, Laakso M: Dyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with NIDDM. Diabetes. 1997, 46: 1354-1359. 10.2337\/diabetes.46.8.1354.","journal-title":"Diabetes"},{"key":"116_CR35","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","unstructured":"UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998, 352: 837-853. 10.1016\/S0140-6736(05)61359-1.","journal-title":"Lancet"},{"key":"116_CR36","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1056\/NEJM199309303291401","volume":"329","author":"The Diabetes Control and Complications Trial Research Group","year":"1993","unstructured":"The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993, 329: 977-986. 10.1056\/NEJM199309303291401.","journal-title":"N Engl J Med"},{"key":"116_CR37","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.metabol.2003.10.025","volume":"53","author":"T Yanagawa","year":"2004","unstructured":"Yanagawa T, Araki A, Sasamoto K, Shirabe S, Yamanouchi T: Effect of antidiabetic medications on microalbuminuria in patients with type 2 diabetes. Metabolism. 2004, 53: 353-357. 10.1016\/j.metabol.2003.10.025.","journal-title":"Metabolism"},{"key":"116_CR38","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/j.1463-1326.2005.00475.x","volume":"8","author":"GT Ko","year":"2006","unstructured":"Ko GT, So WY, Chan NN, Chan WB, Tong PC, Li J, Yeung V, Chow CC, Ozaki R, Ma RC, Cockram CS, Chan JC: Prediction of cardiovascular and total mortality in Chinese type 2 diabetic patients by the WHO definition for the metabolic syndrome. Diabetes Obes Metab. 2006, 8: 94-104. 10.1111\/j.1463-1326.2005.00475.x.","journal-title":"Diabetes Obes Metab"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2840-6-37.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T07:23:18Z","timestamp":1630480998000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/1475-2840-6-37"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["116"],"URL":"https:\/\/doi.org\/10.1186\/1475-2840-6-37","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12]]},"assertion":[{"value":"24 September 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2007","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2007","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"37"}}